ArticleMayo Clinic proceedings2009

Targeting the pathogenic role of interleukin 1{beta} in the progression of smoldering/indolent myeloma to active disease.

Charles A DinarelloPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.